Retatrutide is an peptide drug that promotes weight loss by simultaneously activating three hormone receptors: GLP-1, GIP, and glucagon. GLP-1 receptor activation reduces appetite and slows digestion, leading to lower food intake, while GIP helps regulate glucose and may support fat metabolism. Glucagon receptor activation increases energy expenditure by stimulating fat burning. Together, these mechanisms create a caloric deficit, resulting in significant body weight reduction.
TB-500 is a peptide derived from thymosin beta-4, a naturally occurring protein involved in tissue regeneration and repair. It promotes cell migration, angiogenesis, and wound healing while reducing inflammation and scar tissue formation. Because of these properties, TB-500 has been studied for accelerating recovery from injuries to muscles, tendons, ligaments, and other soft tissues.
BPC-157 is a peptide derived from a naturally occurring protein in human gastric juice, and it is studied for its tissue-protective and regenerative properties. It promotes healing of tendons, ligaments, muscles, and bones, and enhances angiogenesis, which supports recovery from injuries. BPC-157 has also shown potential for protecting the gastrointestinal tract and reducing inflammation.
GHK-Cu+ is a naturally occurring tripeptide that binds copper ions, forming a biologically active complex. It plays a critical role in tissue repair, skin regeneration, and anti-aging processes by stimulating collagen and elastin production, modulating inflammation, and influencing gene expression. Widely studied in cosmetic and regenerative medicine research, GHK-Cu has shown potential to improve wound healing, reduce oxidative stress, and promote hair growth.
